BlackRock Health Sciences Term Trust (BMEZ) To Go Ex-Dividend on August 14th

BlackRock Health Sciences Term Trust (NYSE:BMEZ) declared a monthly dividend on Friday, June 5th. Investors of record on Friday, August 14th will be given a dividend of 0.11 per share on Monday, August 31st. This represents a c) annualized dividend and a dividend yield of 8.2%. The ex-dividend date is Friday, August 14th.

BlackRock Health Sciences Term Trust Price Performance

NYSE BMEZ opened at $16.16 on Wednesday. BlackRock Health Sciences Term Trust has a one year low of $13.70 and a one year high of $16.20. The business has a fifty day moving average price of $15.16 and a 200 day moving average price of $14.75.

Institutional Trading of BlackRock Health Sciences Term Trust

A number of hedge funds have recently bought and sold shares of the business. Saba Capital Management L.P. purchased a new stake in shares of BlackRock Health Sciences Term Trust in the 1st quarter valued at approximately $10,907,000. Rivernorth Capital Management LLC lifted its holdings in BlackRock Health Sciences Term Trust by 195.8% in the fourth quarter. Rivernorth Capital Management LLC now owns 648,567 shares of the company’s stock valued at $9,761,000 after acquiring an additional 429,291 shares during the last quarter. Lazard Asset Management LLC purchased a new position in BlackRock Health Sciences Term Trust in the fourth quarter worth approximately $5,697,000. Invesco Ltd. increased its stake in BlackRock Health Sciences Term Trust by 42.7% during the third quarter. Invesco Ltd. now owns 929,121 shares of the company’s stock worth $13,398,000 after acquiring an additional 278,024 shares during the last quarter. Finally, Wolverine Asset Management LLC raised its position in BlackRock Health Sciences Term Trust by 78.8% in the fourth quarter. Wolverine Asset Management LLC now owns 401,511 shares of the company’s stock valued at $6,043,000 after purchasing an additional 176,993 shares during the period.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.